The S100A8/A9-mediated ROS suppression was reported to improve the CD4+ T cell accumulation in TME of breast cancer, which has been known to be regulated in STAT3-dependent mechanism in MDSCs [54, 58, 59, 61]. This evidence concerns the gene CD4 and breast carcinoma.